Pfizer said on Friday that the COVID-19 vaccine it developed together with BioNTech showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old.
156 children in the trial who had received a placebo got COVID-19, compared with 3 who were vaccinated, Pfizer said in briefing documents submitted to the US Food and Drug Administration and quoted by Reuters.
(Arutz Sheva’s North American desk is keeping you updated until the start of Shabbat in New York. The time posted automatically on all Arutz Sheva articles, however, is Israeli time.)
Read more